What Is My Insurance Agency Worth? How Buyers Value It
A plain-English valuation guide for owners of $5M–$200M insurance agencies — what a PE-hybrid consolidator actually pays, and the levers that move your multiple by four to six full turns.
Updated 2026-06-12·Updated 2026 · 12 min read·Business & Professional Services
Typical multiple
6x – 14x
Priced on Adjusted EBITDA · Typical 11.6x
Sica|Fletcher 450+ sell-side dataset (H1 2025); OPTIS Partners H1 2025 (319 transactions); Sica|Fletcher full-year 2025 total of 714 brokerage transactions
- Adjusted EBITDA range (LMM)
- 6x – 14x
- Avg. multiple, $1M+ EBITDA deals (H1 2025)
- 11.8x
- Typical EBITDA margin
- 15–20%
- Announced broker M&A deals in 2025
- 854
The short answer
A lower-middle-market insurance agency is worth a multiple of its normalized EBITDA — and the range is unusually wide. In 2026, most $5M–$200M agencies trade at 6x to 14x adjusted EBITDA (around an 11.6x midpoint for solid mid-market firms), while small personal-lines books may be valued on a 1.0x–2.5x commission/revenue multiple instead.[1][6] Book retention and line-of-business mix are the two decisive levers inside that band.[6][7]
Estimate vs. reality
A calculator estimate is not what a buyer pays
A free online calculator will multiply your revenue or earnings by a generic insurance-agency rule of thumb — often the old "1.5x commissions" shorthand — and hand you a number. A real buyer pays a price grounded in normalized EBITDA, book-quality underwriting, and competitive bid tension. That gap routinely moves value 30–50% in either direction, and Sica|Fletcher reports that agencies run through a proper sell-side process trade approximately 25% higher than off-market negotiations.[1]
- Revenue or commissions × a single generic insurance multiple
- Often anchored to the outdated 1.5x-commissions rule of thumb
- No distinction between personal-lines (5–7x EBITDA) and specialty/EB books (9–12x EBITDA)
- No add-back normalization — misses owner-producer commission carve-outs and contingent-income smoothing
- No view of deal structure: cash-at-close percentage, rollover equity, or earn-out terms
- Adjusted EBITDA normalized for owner-producer comp, contingent-income smoothing, and family payroll
- A multiple set by book retention bracket (90%+ vs. sub-80%) and LOB mix (PL vs. commercial vs. specialty/EB)
- Competitive bid tension — auctions with up to 10 bids per sell-side process at mid-market
- Producer non-compete enforceability modeled as a separate book-risk variable
- A structured price: cash at close, mandatory rollover equity, and a commission/EBITDA earn-out tied to post-close retention
The 1.5x-commissions rule of thumb can undervalue a high-retention commercial agency by 30% or more once EBITDA normalization and a competitive buyer process are applied.[1][6]
Earnings basis
SDE or EBITDA? It depends on your size
Insurance agencies are valued on two different earning metrics depending on size and transaction type. Small book-of-business fold-ins under roughly $1M revenue are priced on a commission or revenue multiple, because owner compensation distorts EBITDA at that scale. Going-concern agency sales above that threshold are priced on adjusted EBITDA, normalized for owner-producer pay, contingent-commission smoothing, and family payroll.[1][4][6] MarshBerry's proprietary transaction data — drawn from over 800 annual M&A advisory mandates — confirms that EBITDA normalization is the most consequential pre-market step for agency owners.[9]
| Business size | Priced on | Typical multiple | What's going on |
|---|---|---|---|
| Under ~$1M revenue (book fold-in) | Revenue / commission multiple | 1.0x – 2.5x commissions | Personal-lines fold-ins; owner carries most client relationships; buyer prices in attrition risk. BizBuySell's average earnings multiple for small insurance agencies was ~2.68x in 2024–25.[10] |
| $2M – $10M EV (small going-concern) | Adjusted EBITDA | 5x – 8x | Personal-lines-heavy books at the low end (5–7x); commercial-led books with solid retention toward the top (7–8x). Owner-operator buyers and smaller PE-hybrid fold-ins dominate.[6][7] |
| $10M – $50M EV (mid-market) | Adjusted EBITDA | 11.4x – 11.8x | Sica|Fletcher core band for $1M+ EBITDA deals in H1 2025 — the most competitive buyer pool, with BroadStreet, Hub, Inszone, and Acrisure all active.[1] |
| $50M+ EV (platform / specialty) | Adjusted EBITDA | 14x – 16x+ | Anchored by Gallagher–AssuredPartners (~14.3x EBITDAC gross) and Brown & Brown–Risk Strategies (~16x on ~$600M EBITDA). Specialty/EB mix, 90%+ retention, and 15%+ organic CAGR required.[2] |
Per the IBBA/M&A Source Market Pulse framing, businesses valued under ~$2M are priced on SDE; those valued at $2M and above shift to adjusted EBITDA, with a market-rate replacement manager subtracted rather than full owner pay added back.[8][8]
Interactive estimate
Estimate what your insurance agency is worth
Move the sliders. The range reflects how each driver pushes the multiple up or down for a insurance agency. Treat it as a planning anchor — not a formal valuation.
The single biggest driver in insurance M&A. 90%+ retention earns premium pricing and high cash-at-close; sub-80% compresses the multiple by 2–3 turns and triggers heavy earn-outs.
Personal-lines P&C trades at 5–7x; commercial 7–10x; specialty/employee benefits 9–12x. Moving from 70% PL to 60%+ specialty/EB can shift you 3–4 turns inside the band.
Contingent commissions are volatile and discounted in normalized EBITDA. Buyers smooth to a 3-year rolling average; high contingent reliance reduces the defensible EBITDA base.
With commercial P&C rate change at only +0.2% by Q4 2025 (down from +11.7% peak), organic growth is the cleanest signal of real producer strength. 15%+ CAGR earns platform-tier pricing.
Estimated enterprise value
$17.1M – $17.7M
Implied multiple: 11.4x – 11.8x Adjusted EBITDA
Illustrative planning range only, based on Sica|Fletcher H1 2025 mid-market data and driver sensitivities — not a formal valuation or an offer.
Methodology
The three ways a insurance agency gets valued
A credible valuation triangulates across all three. Any single number in isolation is suspect.
Market approach — comparable insurance brokerage transactions
The primary method for all going-concern agenciesThe market approach values your agency against actual sale prices of comparable insurance brokerages. It dominates because the PE-hybrid consolidator market generates a dense, current population of private comps — Sica|Fletcher's 450+ sell-side deal dataset and OPTIS Partners' 319-transaction H1 2025 tally are among the richest private-company comp sets in any LMM vertical.[1][3] Buyers and advisors anchor the range on retention bracket and LOB mix first, then adjust for organic growth, carrier concentration, and producer non-compete enforceability.[6][7]
Two practical cautions: the headline platform trades — Gallagher–AssuredPartners at ~14.3x EBITDAC gross and Brown & Brown–Risk Strategies at ~16x — are ceiling prints, not mid-market benchmarks.[2] And agencies valued on a commission multiple (fold-in books) and agencies valued on EBITDA (going concerns) should not share a comp set — they are different markets with different buyer pools.[6]
Income approach — DCF with explicit retention modeling
Secondary cross-check; strongest for specialty and EB booksThe income approach discounts forecast cash flows to present value. In insurance brokerage it is most useful for modeling the renewal book separately from new-business production — a five-year cash flow with an explicit book retention curve, contingent-commission smoothing to a three-year rolling average, and producer non-compete enforceability assumptions.[1] Terminal value is anchored to a market exit multiple at platform scale (12–14x), not a perpetuity assumption.
The normalization benchmark buyers apply before calculating terminal value is an EBITDA target margin of 24.5–26% ex-contingents per Sica|Fletcher.[1] Agencies with contingent income above 15% of revenue face haircuts on the defensible EBITDA base, which flows directly into the DCF terminal value. The income approach carries more weight for specialty and employee-benefits books whose renewal annuities are forecastable over a five-year horizon.[6]
Asset approach — adjusted net assets
Floor only; rarely drives insurance agency valueThe asset approach sums the market value of tangible and intangible assets net of liabilities. For an insurance agency it almost never drives the operating value — the core asset is the renewal book (a stream of future commission income), which is an intangible captured by the market and income approaches.[6] The asset approach sets a practical floor in distressed situations: a book with very low retention and a departing owner-producer might be valued on a run-off basis, but that floor is typically expressed as a 1.0–1.5x commission multiple rather than as a traditional net-asset calculation.[7]
Value drivers
What moves the multiple for a insurance agency
Book retention above 90%
+1.5x to +3.0xBook retention is the single largest internal lever in insurance M&A. 90%+ retention is the entry ticket to premium pricing and high cash-at-close; Sica|Fletcher's sell-side dataset confirms retention above 90% consistently commands multiples at or above the 11.8x H1 2025 average for $1M+ EBITDA deals.[1] Buyers verify three-year rolling retention at the premium level — not just policy count — in the first diligence round, and re-cut offers if the actual number differs materially from the CIM.[6]
Specialty or employee-benefits LOB mix
+2.0x to +4.0xSpecialty and employee-benefits books trade at 9–12x EBITDA while personal-lines P&C trades at 5–7x — the single largest LOB lever in the sector.[6][7] An agency that moves its revenue mix from 70% PL to 60%+ specialty/EB can pick up 3–4 turns even without growing EBITDA, because specialty/EB renewal annuities are stickier and the program expertise is harder to recreate organically. Construction LOB, healthcare-sector P&C, cyber liability, and professional liability are the niche programs that PE-hybrid consolidators pay the most to acquire.[6]
15%+ organic growth CAGR (rate-adjusted)
+0.5x to +1.5xWith commercial P&C rate change moderating to +0.2% by Q4 2025 from a peak of +11.7% in Q3 2020, organic growth is the cleanest signal of real producer strength — buyers can no longer attribute top-line expansion to favorable rate cycles.[1] A three-year organic CAGR above 15% (excluding market-rate tailwinds) is underwritten as the proxy for forward EBITDA durability and earns platform-tier pricing from BroadStreet, Hub, and Acrisure.[3]
Commercial-lines mix with diversified carrier panel
+0.5x to +1.5xCommercial books at $2–15M revenue trade at 2.0–3.0x revenue or 7–9x EBITDA as a going concern, compared with 1.5–2.0x revenue or 5–7x EBITDA for comparable personal-lines agencies.[6] A diversified carrier panel — no single carrier above ~40% of placed premium — directly reduces the book-transition risk that buyers model in diligence.[7]
Personal-lines-heavy book
−2.0x to −4.0xPL P&C books trade at 5–7x EBITDA or 1.5–2.0x revenue, versus the 11.4–11.8x mid-market band, because personal lines carry higher attrition risk, lower margin, and greater carrier commoditization.[6][7] The most common reason an otherwise solid agency lands at the bottom of the range is a book that is 60–70%+ PL by revenue. BizBuySell's average earnings multiple for small insurance agencies was only ~2.68x in 2024–25, below the five-year average of 2.86x — that reflects small PL-heavy owner-run reality, not the PE-hybrid headlines.[10]
Book retention below 80%
−1.5x to −3.0xSub-80% retention triggers material multiple compression and earn-out-heavy structures — typically 12–24-month commission-based or EBITDA-based holdbacks that transfer post-close attrition risk to the seller.[6][7] At 75% retention or below, some PE-hybrid platforms will not underwrite the deal on an EBITDA-multiple basis at all, falling back to a 1.0–1.5x commission fold-in structure. Document the cause of any one-time book loss before the sale process begins.[6]
Producer or client concentration
−1.0x to −2.0xA single producer driving more than 25% of revenue, or a single client representing more than 10–15% of revenue, both compress the multiple — buyers price in the risk that revenue walks with the person or account.[6] PE-hybrid platforms use producer concentration as a hard filter: agencies above the danger lines face either a producer retention escrow, a heavier earn-out, or a lower headline price. Begin diversifying at least 18–24 months before a planned sale.[3]
High contingent-commission reliance
−0.5x to −1.0xContingent commissions (carrier profit-sharing) are volatile and explicitly discounted in normalized EBITDA. Sica|Fletcher's target EBITDA margin of 24.5–26% is calculated ex-contingents — buyers smooth contingents to a three-year rolling average and underwrite a lower forward run-rate.[1] Agencies with TTM contingents spiking above the three-year average see the excess stripped from the defensible EBITDA base, which reduces the multiple anchor even if the headline multiple stays unchanged.
Worked example
A $10M-revenue commercial P&C and employee-benefits agency, step by step
An illustrative mid-size agency with a mixed commercial P&C and employee-benefits book, 91% three-year rolling retention, diversified carrier panel, and a tenured account team that does not depend on the founding owner for renewals. Numbers are illustrative, not a specific company.
Annual revenue (commissions + fees)
$10.0M
60% commercial P&C, 30% employee benefits, 10% personal lines
Adjusted EBITDA
$2.0M
≈20% margin after owner add-backs, contingent normalization[5][11]
Applied multiple
8.0x
Commercial/EB mix, 91% retention, solid organic growth — lower mid-market band[1][6]
Enterprise value
≈ $16.0M
Adjusted EBITDA × multiple
Indicative result
≈ $16.0M enterprise value
A personal-lines variant illustrates the other half of the story: the same $10M revenue at 15% EBITDA margin is $1.5M EBITDA — and at a 5.5x PL-book multiple, enterprise value falls to ≈$8.25M.[6][7] Identical revenue, near-identical earnings scale, yet the LOB mix alone produces a $7.75M spread in value. This example is illustrative and not an offer or formal valuation.
Cost & who does it
What a insurance agency valuation costs — and who should do it
Before anchoring on any number, get your normalized EBITDA right — particularly the owner-producer commission carve-out and contingent-income smoothing, which are the two most commonly misstated figures in agency financials.[1][11] The right valuation tool depends on why you need the number.
Broker / advisor opinion of value
Free – $5,000
Best for
Testing the market, setting a listing range, annual value tracking
Fast; not certified; not accepted by the IRS or courts. Specialist insurance M&A advisors — MarshBerry, Reagan Consulting, Sica|Fletcher, SICA Fletcher — provide initial assessments; many are free to win the engagement.[12][13]
Formal certified appraisal (USPAP)
$5,000 – $30,000+
Best for
Estate or gift tax, ESOP, litigation, partner buyout, SBA
Performed by a credentialed appraiser (CVA / ABV / ASA); defensible to the IRS and courts. Entry ~$5,000; complex multi-entity reports $15,000–$50,000+.[12][14]
Quality of earnings (QoE)
$15,000 – $75,000+
Best for
Validating adjusted EBITDA before going to market
Not an audit; tests add-backs, contingent normalization, and working capital. Across 360 GF Data-tracked deals, sellers with a sell-side QoE realized ~half a turn higher TEV/EBITDA on average.[15]
For most $5M–$200M insurance agency owners the practical sequence is: an advisor opinion of value to orient (often free from a specialist insurance M&A advisor), a sell-side QoE to document and defend normalized EBITDA before going to market, and a certified appraisal only if a tax, legal, or ESOP trigger requires it. Standard non-certified valuations typically run ~$1,000–$5,000; certified appraisals ~$5,000–$8,000+, and up to $15,000–$30,000+ for complex multi-entity structures.[12][13] Ad Astra has closed over $1B in verified lower-middle-market transaction value — a confidential opinion of value is a no-obligation place to start. Book a confidential call.
Before you sell
How to increase your valuation before going to market
The gap between a 5x personal-lines book and an 11x–14x specialty-commercial platform is built over 12–36 months, not discovered at closing. Our value enhancement work is structured around the three levers that move insurance agency multiples most decisively — LOB mix, book retention, and the normalization story you bring to market.
Shift LOB mix toward commercial, specialty, and employee benefits
+2.0x to +4.0xThe most powerful lever in insurance agency M&A is not EBITDA growth — it is mix shift. Moving from 70% personal-lines revenue to 60%+ commercial or specialty/EB can add 3–4 turns of multiple on the same EBITDA base, and the specialty/EB renewal annuity is stickier and harder for a buyer to recreate organically.[6] Targeted producer hires or small book acquisitions in construction, professional liability, cyber, or employee benefits are the fastest paths. Eighteen to 24 months of demonstrated mixed-book results before going to market is the minimum credible track record buyers will accept.
Drive three-year rolling book retention above 90%
+1.5x to +3.0xRetention is the metric buyers verify first and trust most. Three-year rolling retention above 90% (measured at the premium level, not just policy count) consistently commands the upper end of the mid-market band and earns the highest cash-at-close percentage.[1][6] Concrete actions: implement formal renewal review workflows, document producer transition protocols, and install AMS-generated retention dashboards you can show in a CIM — buyers specifically distrust agencies that can only produce spot-year retention figures.
Normalize and document EBITDA before the process
+0.5x – +1.0x on realized multiple, or +15%–40% on EBITDA baseOwner-producer commission carve-outs, family payroll adjustments, and contingent-commission smoothing are the three most commonly understated normalizations in agency financials.[1][11] An undocumented add-back schedule is the single most common cause of buy-side re-trades — a sell-side QoE that validates the adjustments before you go to market shifts the burden of proof to the buyer.[15] GF Data's analysis of 360 tracked deals found sellers with a sell-side QoE realized approximately half a turn higher TEV/EBITDA on average.[15]
Reduce producer and carrier concentration before going to market
Avoids −1.0x to −2.0x discountA single producer driving more than 25% of revenue, or a single carrier representing more than 40% of placed premium, are the two most common hard filters PE-hybrid buyers apply in diligence.[6] Adding two or three mid-sized producers who each drive 8–12% of revenue, and broadening the carrier panel before a sale process, removes the concentration discount and often allows the buyer to increase the cash-at-close percentage — reducing the earn-out component that sellers typically find the least attractive part of deal structure.[3]
FAQ
Common questions about insurance agency valuation
Go deeper on insurance agency multiples
Value another business
From estimate to real number
Get an owner-grade valuation of your insurance agency
A confidential 30-minute call with Clayton or Joe gives you a real range, the adjustments we'd apply to your reported earnings, and the one or two moves that close the gap fastest — built on business & professional services deal data.
- [1] 2025 Insurance Broker M&A Valuations — Interest Rates, Spreads & Deal Volume — Sica|Fletcher, 2025
- [2] Insurance Broker Valuations — Insurance Journal, March 26, 2026
- [3] Insurance Agency M&A Market Settles Into New Normal as Consolidation Accelerates (OPTIS Partners) — Risk & Insurance, 2025
- [4] MarshBerry — How To Calculate An Insurance Firm's Valuation
- [5] Risk & Insurance — Best Practices Study EBITDA Margins 2025
- [6] Insurance Agency Business Valuation — CT Acquisitions, 2026
- [7] How Much Is My Insurance Agency Worth — Wexford Insurance, 2026
- [8] IBBA & M&A Source — Market Pulse Q3 2025 Highlights (PDF)
- [9] MarshBerry — Insurance Brokerage M&A Stays Active in 2025 Amid Market Headwinds
- [10] Insurance Agency Valuation Benchmarks — BizBuySell
- [11] MidStreet — Adjusted EBITDA: Add-backs and Common Errors
- [12] Baton — How Much Does a Business Appraisal Cost?
- [13] Sofer Advisors — Certified Valuation vs. Broker Opinion
- [14] Eton Venture Services — How Much Do Business Valuation Services Cost in 2026?
- [15] Middle Market Growth (ACG) / GF Data — New Fields, New Fruit: Sell-Side QoE Multiple Lift
Ranges represent typical lower middle market transactions; individual deals may fall outside the band based on buyer thesis, deal structure, and company-specific factors. This page is informational and not a formal valuation opinion.